Publications by authors named "K Nowicka-Matus"

Claim this Profile
P
Pembrolizumab as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a multi-institutional DAHANCA cohort study.
Sebastian Søby, Robin Prestwich, Niels Gyldenkerne, Christian Maare, Camilla K Lonkvist, Kinga Nowicka-Matus

Acta Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial cosmetic outcome six months after kilovoltage therapy of facial basal cell carcinoma: A Danish national prospective study of 932 patients.
O N Braendstrup, P Lassen, A B Gothelf, S R De Blanck, J Friborg, K Nowicka-Matus

Sci Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute toxicities in proton therapy for head and neck cancer - A matched analysis of the DAHANCA 35 feasibility study.
K Nowicka-Matus, J Friborg, C R Hansen, M Bernsdorf, U V Elstrøm

Clin Transl Radiat Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interobserver variation in organs at risk contouring in head and neck cancer according to the DAHANCA guidelines.
Camilla Panduro Nielsen, Ebbe L Lorenzen, Kenneth Jensen, Jesper Grau Eriksen, Jørgen Johansen, Kinga Nowicka-Matus

Radiother Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scrotal Paget's Disease Associated With Human Epidermal Growth Factor Receptor 2-Overexpressing Metastatic Apocrine Carcinoma With Complete Response to Paclitaxel, Trastuzumab, and Pertuzumab.
Kinga Nowicka-Matus, Giedrius Salkus, Mads Sønderkær, Inge Søkilde Pedersen, Anja Ernst

JCO Precis Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis